Company Filing History:
Years Active: 2025
Title: Christian Dank: Innovator in Oncological Treatments
Introduction
Christian Dank is a notable inventor based in Deutschkreutz, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative treatments for oncological diseases.
Latest Patents
Dank holds a patent for "Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and/or SMARCA4." This invention encompasses compounds that serve as degraders of specific proteins, which are crucial in the treatment and prevention of cancer. The patent details the use of these compounds in pharmaceutical compositions and their potential as medical agents.
Career Highlights
Christian Dank is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work focuses on developing novel therapeutic strategies that target cancer-related pathways.
Collaborations
Dank collaborates with esteemed colleagues, including Alessio Ciulli and Emelyne Diers, who contribute to the advancement of research in this vital area of medicine.
Conclusion
Christian Dank's innovative work in the field of oncology exemplifies the impact of targeted therapies in modern medicine. His contributions continue to pave the way for new treatment options for patients battling cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.